166 related articles for article (PubMed ID: 34463970)
1. A special issue on modern genomics in diagnostic haematology.
Br J Haematol; 2021 Sep; 194(5):801-802. PubMed ID: 34463970
[No Abstract] [Full Text] [Related]
2. Next generation sequencing in hematolymphoid neoplasia.
Kuo FC
Semin Hematol; 2019 Jan; 56(1):2-6. PubMed ID: 30573040
[TBL] [Abstract][Full Text] [Related]
3. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
4. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
6. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
7. [Genomics-based precision medicine in hematology/oncology].
Maeda T
Rinsho Ketsueki; 2021; 62(8):1004-1011. PubMed ID: 34497186
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for hematologic cancers.
Misra RR; Pinsky PF; Srivastava S
Hematol Oncol Clin North Am; 2000 Aug; 14(4):907-24, ix-x. PubMed ID: 10949780
[TBL] [Abstract][Full Text] [Related]
9. Using genomics to define pediatric blood cancers and inform practice.
Rau RE; Loh ML
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):286-300. PubMed ID: 30504323
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
11. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
12. Diagnostics with modern genomics.
Brugnara C
Am J Hematol; 2021 Nov; 96(11):E447. PubMed ID: 34536026
[No Abstract] [Full Text] [Related]
13. [The current status of genetic testing for leukemia].
Satoh Y; Masuda A; Yokota H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):369-77. PubMed ID: 25022066
[TBL] [Abstract][Full Text] [Related]
14. Role of cell-free DNA in haematological malignancies.
Lim JK; Kuss B; Talaulikar D
Pathology; 2021 Apr; 53(3):416-426. PubMed ID: 33648721
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
16. Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.
Corboy G; Othman J; Lee L; Wei A; Ivey A; Blombery P; Agarwal R; Fong C; Brown A; Scott H; Grove C; Louw A; Enjeti A; Iland H; Paul C; Bohlander S; Kakadia P; Horan M; Stevenson W
Pathology; 2021 Jun; 53(4):487-492. PubMed ID: 33272691
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies.
Demeter J; Messer G; Rämisch S; Mee JB; di Giovine FS; Schmid M; Herrmann F; Porzsolt F
Cytokines Mol Ther; 1996 Dec; 2(4):239-42. PubMed ID: 9384710
[TBL] [Abstract][Full Text] [Related]
18. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
[TBL] [Abstract][Full Text] [Related]
19. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
20. Ethical considerations in genomic testing for hematologic disorders.
Marron JM; Joffe S
Blood; 2017 Jul; 130(4):460-465. PubMed ID: 28600340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
